LI Xin, ZHANG Yingkui, CAO Kangxi, YUAN Qinghai. Multimodal Imaging Finding of a Young Patient with Stroke: A Case Report[J]. Chinese Journal of Stroke, 2022, 17(03): 314-317.
[1] CAMPBELL B C V，DE SILVA D A，MACLEOD M R，et al. Ischaemic stroke[J/OL]. Nat Rev Dis Primers， 2019，5（1）：70[2022-01-15]. https://doi.org/10.1038/s41572-019-0118-8.
[2] XU Y Y，LI M L，GAO S，et al. Etiology of int racranial stenosis in young patients：a highresolution magnetic resonance imaging study[J/OL]. Ann Transl Med，2017，5（16）：319[2022-01-15]. https://dx.doi.org/10.21037/atm.2017.06.31.
[3] YANG W J，CHEN X Y，ZHAO H L，et al . Postmortem study of validation of low signal on fatsuppressed T1-weighted magnetic resonance imaging as marker of lipid core in middle cerebral artery atherosclerosis[J]. Stroke，2016，47（9）：2299-2304.
[4] GAO T L，YU W，LIU C J. Mechanisms of ischemic stroke in patients with intracranial atherosclerosis：a high-resolution magnetic resonance imaging study[J]. Exp Ther Med，2014，7（5）：1415-1419.
[5] RYOO S，CHA J，KIM S J，et al. High-resolution magnetic resonance wall imaging f indings of Moyamoya disease[J]. Stroke，2014，45（8）：2457-2460.
[6] TAKAGI Y，KIKUTA K，NOZAKI K，et al . Histological features of middle cerebral arteries from patients treated for Moyamoya disease[J]. Neuro Med Chir，2007，47（1）：1-4.
[7] KIM J M，JUNG K H，SOHN C H，et al. Highresolution MR technique can distinguish Moyamoya disease from atherosclerotic occlusion[J]. Neurology，2013，80（8）：775-776.
[8] 王可颜，程敬亮，张勇，等. 高分辨率MRI在鉴别烟雾病和动脉粥样硬化相关性烟雾综合征中的应用价值[J]. 中华放射学杂志，2017，51（1）：3-7.
[9] SCOTT R M，SMITH E R. Moyamoya disease and Moyamoya syndrome[J]. N EnglJ Med，2009，360（12）：1226-1237.
[10] JIANG T，PERRY A，DACEY R G，et al. Intracranial atherosclerotic disease associated with Moyamoya collateral formation：histopathological findings[J]. J Neurosurg，2013，118（5）：1030-1034.
[11] 赵维纳，贾龙飞，韩璎. 颅内动脉易损性粥样硬化斑块MRI研究进展[J]. 中华放射学杂志，2013，（5）：465-468.
[12] 彭雯佳，陆建平. 动脉粥样硬化管壁的多对比高分辨率MRI研究进展[J]. 中华放射学杂志，2015，49（8）：637-640.
[13] JO K I，YEON J Y，HONG S C，et al. Clinical course of asymptomatic adult Moyamoya disease[J]. Cerebrovasc Dis，2014，37（2）：94-101.
[14] EKKER M S，BOOT E M，SINGHAL A B，et al. Epidemiology，aetiology，and management of ischaemic stroke in young adults[J]. Lancet Neurol，2018，17（9）：790-801.
[15] KRISHNAMURTHI R V，MORAN A E，FEIGIN V L，et al. Stroke prevalence，mortality and disabilityadjusted life years in adults aged 20-64 years in 1990-2013：data from the global burden of disease 2013 study[J]. Neuroepidemiology，2015，45（3）：190-202.
